Clinical Trial Update: V114 and Acute Otitis Media (V114-032/PNEU-ERA) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating V114 for acute otitis media has completed enrollment and the study status is updated to completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• V114 (15-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Acute Otitis Media (AOM) | Phase 3 | Status: COMPLETED